• Publications
  • Influence
Emergency and prophylactic use of miniaturized veno‐arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation
To report our center's experience using veno‐arterial extracorporeal membrane oxygenation (vaECMO) in transcatheter aortic valve implantation (TAVI).
  • 30
  • 4
Multicenter Comparison of Novel Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves.
OBJECTIVES This study sought to compare 2 next-generation transcatheter heart valves (THV), the self-expanding ACURATE neo (NEO) and the balloon-expandable SAPIEN 3 (S3), in terms of device failureExpand
  • 43
  • 3
Prosthesis sizing for transcatheter aortic valve implantation--comparison of three dimensional transesophageal echocardiography with multislice computed tomography.
BACKGROUND The complex anatomy of the aortic annulus warrants the use of three dimensional (3D) modalities for prosthesis sizing in transcatheter aortic valve implantation (TAVI). Multislice computedExpand
  • 63
  • 2
Single Institution Experience With Transcatheter Valve-in-Valve Implantation Emphasizing Strategies for Coronary Protection.
BACKGROUND Transcatheter valve-in-valve (VIV) implantation evolved as a therapeutic alternative, despite an increased risk of coronary obstruction in comparison with a regular transcatheter aorticExpand
  • 23
  • 2
Transcatheter Valve SELECTion in Patients With Right Bundle Branch Block and Impact on Pacemaker Implantations.
OBJECTIVES This study sought to evaluate the impact of the ACURATE neo (NEO) (Boston Scientific, Marlborough, Massachusetts) versus SAPIEN 3 (S3) (Edwards Lifesciences, Irvine, California) onExpand
  • 9
  • 2
Efficiency in Extracorporeal Membrane Oxygenation—Cellular Deposits on Polymethypentene Membranes Increase Resistance to Blood Flow and Reduce Gas Exchange Capacity
Bioline-coated polymethylpentene (PMP) membrane oxygenators (MO) are used for extracorporeal membrane oxygenation (ECMO) to improve gas exchange in patients with severe acute respiratory distressExpand
  • 48
Tumor marker carbohydrate antigen 125 predicts adverse outcome after transcatheter aortic valve implantation.
OBJECTIVES This study sought to predict the value of tumor marker carbohydrate antigen 125 (CA125) before and after transcatheter aortic valve implantation (TAVI) for all-cause death and a compositeExpand
  • 27
Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two‐center experience of incidence, outcome and temporal trends from 2010 to 2015
Although the incidence of periprocedural complications has decreased in transcatheter aortic valve implantation (TAVI), life‐threatening complications occur and emergency veno‐arterial extracorporealExpand
  • 10
Long-term survival and quality of life after extracorporeal life support: a 10-year report†
OBJECTIVES Information is lacking about long-term survival and quality of life (QOL) after treating patients on extracorporeal life support. METHODS Outcome data were assessed by phone interviews,Expand
  • 11
A unique access for the ablation catheter to treat electrical storm in a patient with extracorporeal life support.
AIMS Extracorporeal membrane oxygenation (ECMO) is a very effective bridging therapy in patients with cardiogenic shock. To perform coronary angiography in these patients our group developed anExpand
  • 10